Asian Journal of Research in Pharmaceutical Sciences

Pradeep Sahu ¹, Neha Pinkalwar ¹, Ravindra Dhar Dubey ¹, Shweta Paroha ², Shilpi Chatterjee ¹, Tanushree Chatterjee ¹

Affiliations
1 Institute of Pharmacy, RITEE, Chhatauna, Mandir Hasaud, Raipur, Chhattisgarh, IN
2 Siddhi Vinayaka Institute of Technical Sciences, Mangla, Bilaspur, Chhattisgarh, IN

Abstract

Biomarkers provide a dynamic and powerful approach to understanding the spectrum of disease with applications in observational and analytic epidemiology, randomized clinical trials, screening and diagnosis and prognosis. Defined as alterations in the constituents of tissues or body fluids, these markers offer the means for homogeneous classification of a disease and risk factors, and the can extend our base information about the underlying pathogenesis of disease. A prerequisite for the clinical use of biomarker is elucidation of the specific indication, standardization of analytical methods, characterization of analytical features, incremental yield of different markers for given clinical indications. Biomarkers can also reflect the entire spectrum of disease from the earliest manifestations to the terminal stages. The major use of biomarkers in clinical investigation.

Keywords

Diagnosis, Biomarker, Drug Developments, Disease, Clinical Investigation.

Full Text